A Canadian study has raised new questions about whether some commonly prescribed blood pressure medications could be linked to a higher risk of suicide.
The research has attracted attention because millions of people around the world take these medications every day to manage conditions such as high blood pressure, heart failure, diabetes, and chronic kidney disease.
The study was led by Dr. Muhammad Mamdani from St. Michael’s Hospital in Toronto and was published in the medical journal JAMA Network Open. Researchers examined two major types of blood pressure medications known as Angiotensin Receptor Blockers, commonly called ARBs, and ACE inhibitors.
Both groups of medications are widely used and are considered very effective for treating cardiovascular and kidney-related diseases. They work by targeting a hormone system in the body that helps regulate blood pressure and fluid balance.
One important hormone in this system is called angiotensin II. This hormone causes blood vessels to narrow, which raises blood pressure. Both ARBs and ACE inhibitors reduce the effects of angiotensin II, but they do so in different ways.
ACE inhibitors reduce the production of angiotensin II, meaning the body makes less of the hormone. ARBs work differently by blocking the hormone from attaching to receptors in blood vessels and other tissues.
Although both medications lower blood pressure successfully, researchers wanted to investigate whether they might affect mental health differently.
To study this question, scientists analyzed health records from patients in Canada. They identified 964 people who died by suicide within 100 days after receiving either an ARB or an ACE inhibitor prescription.
The researchers then compared these individuals with more than 3,000 other people of similar age and health status who were also taking the same types of medications but had not died by suicide.
After analyzing the data, the researchers found that people taking ARBs appeared to have a significantly higher risk of suicide compared with people taking ACE inhibitors. According to the study, ARB users had about a 63 percent higher risk of death by suicide.
The findings do not prove that ARBs directly cause suicidal thoughts or suicidal behavior. However, the study suggests there may be a possible connection that deserves much more investigation.
The researchers explored several theories that might explain the findings. One possible explanation involves how angiotensin II may affect the brain.
Some scientists believe ARBs could potentially increase levels of angiotensin II in certain parts of the brain because the hormone is blocked from attaching to receptors elsewhere in the body. Researchers suspect that changes in this hormone system inside the brain might influence mood, stress responses, or mental health.
However, experts stress that this explanation remains theoretical, and scientists still do not fully understand the biological mechanisms involved.
The study also highlighted another important issue. Many of the people included in the research were not only taking blood pressure medications. Some were also using antidepressants, anti-anxiety medications such as benzodiazepines, or other drugs that can affect mood and mental health.
Because of this, researchers say it is difficult to separate the exact influence of the blood pressure medications from other mental health factors.
Mental health itself is highly complex. Depression, anxiety, stress, social isolation, physical illness, chronic pain, financial pressures, and many other factors may all contribute to suicide risk.
This means the study should be interpreted carefully. It identifies a possible association but does not prove direct cause and effect.
The researchers are not advising patients to stop taking ARBs. These medications remain important treatments that help many people lower blood pressure, protect kidney function, and reduce the risk of heart attacks, strokes, and heart failure.
For many patients, ARBs may still be the best or safest medical option depending on their personal health conditions and treatment history.
At the same time, the findings may encourage doctors to pay closer attention to mental health symptoms in patients starting these medications, especially in people who already have depression, anxiety, or previous mental health challenges.
Some experts believe the results may eventually influence prescribing decisions if future studies confirm the findings. For now, researchers say more studies are urgently needed to better understand whether there is truly a biological link between ARBs and suicide risk.
Future research may also help identify whether certain patients are more vulnerable than others or whether specific ARB medications carry higher risks.
Medical experts strongly warn patients not to stop or change their blood pressure medication without first speaking to their healthcare provider. Suddenly stopping blood pressure medicine can be dangerous and may lead to severe increases in blood pressure, heart problems, or strokes.
Anyone taking blood pressure medication who notices mood changes, depression, unusual anxiety, hopelessness, or suicidal thoughts should seek medical help as soon as possible. Early support and treatment can make a major difference.
Doctors say this study is an important reminder that medications may affect both physical and mental health in ways scientists are still discovering. Understanding these effects fully is essential for improving patient safety and developing better treatment strategies.
As researchers continue studying the connection between cardiovascular medications and mental health, patients are encouraged to work closely with healthcare providers, monitor both physical and emotional symptoms, and ask questions about any concerns they may have.
If you care about high blood pressure, please read studies that early time-restricted eating could help improve blood pressure, and natural coconut sugar could help reduce blood pressure and artery stiffness.
For more health information, please see recent studies about added sugar in your diet linked to higher blood pressure, and results showing vitamin D could improve blood pressure in people with diabetes.
The study findings were published in JAMA Network Open.
Copyright © 2026 Knowridge Science Report. All rights reserved.
